We are live on
!
Find out more
BTW
Boston Trust Walden Portfolio holdings
AUM
$13.1B
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+8.06%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.72B
AUM Growth
+$243M
(+3.7%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
11.74%
Holding
344
New
9
Increased
98
Reduced
188
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$42.2M |
| 2 |
Tanger
SKT
|
+$32.1M |
| 3 |
INVX
Innovex International
INVX
|
+$19.5M |
| 4 |
RPC Inc
RES
|
+$17.4M |
| 5 |
Synaptics
SYNA
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$47M |
| 2 |
SAPE
SAPIENT CORP
SAPE
|
+$35.4M |
| 3 |
TIBX
TIBCO SOFTWARE INC
TIBX
|
+$27.1M |
| 4 |
ICU Medical
ICUI
|
+$26.8M |
| 5 |
CRR
Carbo Ceramics Inc.
CRR
|
+$25.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.14% |
| 2 | Technology | 16.28% |
| 3 | Industrials | 13.38% |
| 4 | Healthcare | 12.65% |
| 5 | Consumer Discretionary | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ingredion
INGR
$6.4B
| $367K | 0.01% |
4,320
-520
| -11% | -$41.4K |
|
327
Bank of America
BAC
$436B
| $336K | 0.01% |
18,802
| – | – |
|
328
Parker-Hannifin
PH
$124B
| $329K | ﹤0.01% |
2,550
| – | – |
|
329
McKesson
MCK
$99.5B
| $312K | ﹤0.01% |
1,501
| – | – |
|
|
BHI
330
DELISTED
Baker Hughes
BHI
| $308K | ﹤0.01% |
5,494
-13,100
| -70% | -$739K |
|
331
Eaton
ETN
$155B
| $296K | ﹤0.01% |
4,354
| – | – |
|
332
Northrop Grumman
NOC
$77.8B
| $296K | ﹤0.01% |
2,006
| – | – |
|
333
DuPont de Nemours
DD
$18.9B
| $279K | ﹤0.01% |
2,415
| – | – |
|
334
Starbucks
SBUX
$118B
| $278K | ﹤0.01% |
+6,780
| New | +$265K |
|
335
Mastercard
MA
$487B
| $258K | ﹤0.01% |
3,000
| – | – |
|
336
NextEra Energy
NEE
$185B
| $255K | ﹤0.01% |
9,600
| – | – |
|
337
Henry Schein
HSIC
$9.64B
| $245K | ﹤0.01% |
4,590
-255
| -5% | -$12.7K |
|
|
UN
338
DELISTED
Unilever NV New York Registry Shares
UN
| $245K | ﹤0.01% |
6,265
| – | – |
|
339
Warner Bros
WBD
$63.4B
| $219K | ﹤0.01% |
6,371
| – | – |
|
|
CRR
340
DELISTED
Carbo Ceramics Inc.
CRR
| – | – |
-434,430
| Closed | -$25.7M |
|
|
DRC
341
DELISTED
DRESSER-RAND GROUP INC
DRC
| – | – |
-19,515
| Closed | -$1.6M |
|
|
CVD
342
DELISTED
COVANCE INC.
CVD
| – | – |
-42,319
| Closed | -$3.33M |
|
|
SAPE
343
DELISTED
SAPIENT CORP
SAPE
| – | – |
-2,530,704
| Closed | -$35.4M |
|
|
TIBX
344
DELISTED
TIBCO SOFTWARE INC
TIBX
| – | – |
-1,147,849
| Closed | -$27.1M |
|
Similar funds
TWIM
PFPG
RCMU
EPFB
NMIFOAC
AAMU
MGIA
TG
Boston Trust Walden's Q4 2014 Portfolio in Review
As of Q4 2014, Boston Trust Walden held 344 positions worth $6.72B, up 3.7% from $6.48B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q4 2014: portfolio turnover was 4.1%. Boston Trust Walden opened 9 new positions and exited 5, leaving the 344-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Boston Trust Walden's largest Q4 2014 buy was Steris: 682,719 shares worth $44.3M.
- Boston Trust Walden added most to RPC Inc in Q4 2014, an estimated $17.4M increase.
- Boston Trust Walden's biggest Q4 2014 reduction was SIGMA - ALDRICH CORP, cutting an estimated $47M.
- Boston Trust Walden fully exited SAPIENT CORP in Q4 2014, selling an estimated $35.4M.
- Boston Trust Walden's ten largest holdings make up 12% of its $6.72B portfolio in Q4 2014.
- Boston Trust Walden opened 9 new positions and closed 5 in Q4 2014.
- Boston Trust Walden's portfolio value rose 3.7% quarter-over-quarter to $6.72B.
Based on Boston Trust Walden's 13F filing for Q4 2014, filed 28 Jan 2015.